Acceptability of different oral dosage forms in paediatric patients in hospital setting

Varsha Pokharkar1, Manjusha Sajith1, Thibault Vallet2

  • 1Department of Pharmaceutics, Bharati Vidyapeeth Deemed University Poona College of Pharmacy, Pune, India.

Insights

Paediatric medicine acceptability in India is hindered by a lack of age-appropriate dosage forms. Oral liquids are well-accepted by infants, while tablets are preferred by older children, highlighting formulation needs.

Area of Science:

  • Pharmaceutical Sciences
  • Paediatric Medicine
  • Health Policy

Background:

  • Limited understanding of medicine acceptability hinders development of age-appropriate paediatric medicines globally.
  • Paediatric medicine acceptability varies by country due to cultural, healthcare, and policy differences.

Purpose of the Study:

  • To map the acceptability of oral medicines in hospitalised paediatric patients in India.
  • To identify challenges in adopting age-appropriate paediatric formulations in India.

Main Methods:

  • Observational, cross-sectional study of paediatric patients (<18 years) on oral medication.
  • Utilised the CAST-ClinSearch Acceptability Score Test tool for evaluation.
  • Analysed acceptability across 20 dosage forms and 7 routes of administration.

Main Results:

  • 490 patients recruited; 193 product evaluations conducted.
  • Oral liquids (50%) and tablets (35%) were most common.
  • Oral liquids were positively accepted by infants/toddlers; tablet acceptability improved with age (good from 6 years).

Conclusions:

  • Limited progress in adopting age-appropriate paediatric dosage forms in India.
  • Key challenges include lack of awareness, availability, and child-appropriate medicine policies.
  • Addressing these challenges is crucial for improving medicine acceptability in children.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
23
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
15
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.5K